Janux Therapeutics
JANX
$64.78
Share price
3.76%
Change (1 day)
331.87%
Change (1 year)
Categories
Operating Margin for Janux Therapeutics (JANX)
Operating Margin as of May 2024 (TTM): -739.80%
According to Janux Therapeutics's latest financial reports and stock price the company's current Operating Margin is -739.80%. At the end of 2021 the company had an Operating Margin of -898.32%.
Operating Margin history for Janux Therapeutics from 2021 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -898.32% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.